# Buccal Midazolam Versus Intranasal Dexmedetomidine Plus Oral Chloral Hydrate in Inguinal Hernia Repair

> **NCT06389318** · NA · COMPLETED · sponsor: **Benha University** · enrollment: 80 (actual)

## Conditions studied

- Inguinal Hernia Repair

## Interventions

- **DRUG:** buccal midazolam +oral placebo syrup
- **DRUG:** oral chloral hydrate,intranasal dexmedetomidine and buccal normal saline

## Key facts

- **NCT ID:** NCT06389318
- **Lead sponsor:** Benha University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-03-26
- **Primary completion:** 2024-03-26
- **Final completion:** 2024-04-24
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2024-05-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06389318

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06389318, "Buccal Midazolam Versus Intranasal Dexmedetomidine Plus Oral Chloral Hydrate in Inguinal Hernia Repair". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT06389318. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*